Given that CDDO-Me induces an anti-tumor macrophage phenotype regardless of the cancer genotype in vitro, we sought to determine whether KEAP1 KO tumors respond to CDDO-Me treatment in vivo. The gene discussed is KEAP1; the disease is neoplasm.